Cutoff Value of IC₅₀ for Drug Sensitivity in Patient-Derived Tumor Organoids in Colorectal Cancer

The authors established patient-derived tumor organoids and performed a drug test in 277 samples from 242 colorectal cancer patients who received FOLFOX or XELOX chemotherapy.